戻る
Alaunos Therapeutics Inc (TCRT)価格
TCRT 株価推移チャート
TCRT 収入
Alaunos Therapeutics Inc
$2.64
-2.94%
$-0.08
終値： Feb 11, 16:00:00 GMT-5
$2.72
3.03%
$0.08
アフターマーケット：Feb 11, 20:00:00 GMT-5
最新の利益結果: Q4 '23
報告済み: 2024-04-01
歴史的収益
四半期
年次
EPS
収入
Earnings FAQ
TCRTの最近の1株当たり利益（EPS）は予想と比較してどうでしたか？
Alaunos Therapeutics Inc TCRTの前四半期の収益はどうでしたか？
Alaunos Therapeutics Incの収益見積もりはいくらですか？
Alaunos Therapeutics Incの収益品質スコアはどれくらいですか？
Alaunos Therapeutics Incはいつ収益を報告しますか？
Alaunos Therapeutics Incの予想収益はいくらですか？
Alaunos Therapeutics Incは収益予想を上回りましたか？
主要データ
前終値
$2.72
始値
$2.76
当日レンジ
$2.62 - $2.78
52週レンジ
$1.31 - $6.2
取引高
3.8K
平均取引高
45.6K
1株当たり利益(TTM)
-2.29
配当利回り
--
時価総額
$6.0M
TCRTとは何ですか？
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. The company is headquartered in Fort Lauderdale, Florida and currently employs 1 full-time employees. The company went IPO on 2004-08-20. The firm focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The firm is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The firm has not generated any revenues.